Dr. Reddy’s Enters US OTC Space With Bufferin, Other Ducere Brands
This article was originally published in The Tan Sheet
Executive Summary
Indian generics giant Dr. Reddy’s has made its first foray into the $40bn branded US consumer health goods market, buying half a dozen over-the-counter (OTC) labels, including well-known names like painkiller Bufferin, from Ducere.